Company Limited (“the Company”) would like to clarify the consolidated financial statements of the Company for the 3rd quarter of fiscal year 2018 ended as of September 30, 2018, which can be summarized as
financial aid, Thai Japan Laboratories Co., Ltd. agreed to produce some part of medicine for D.T.C. Industries PLC. to supply and can make the other income. 7.Size of Item The transaction is a financial
warehouse leasing, the contract period is subjected to 3 months. Since Firstwood Co., Ltd. (the lessor) plans to develop the land and to renovate buildings of the rental warehouse, the leasing contract can be
when investment or divestment affects significantly that the Company can have or end its subsidiary status, then, the Company is required to disclose the information to the Stock Exchange of Thailand
a new office in a location that can provide convenience of travelling, not too far from the former office location so as not to affect the employees commuting to work and contact persons, helping
collateral for repayment in the amount of 100 million baht, as well as the subsidiary’s land and buildings as additional collateral for repayment in the amount of 400 million baht, until the Company can repay
regulations, the transaction can be concluded as the followings; 1.2.1 The transaction is defined as the asset acquisition pursuant to the Notification of the Capital Market Supervisory Board TorChor. 20/2551
overall of the Company’s performance can be summarised as follows: (Unit : Thousand Baht ) Performance (Income Statement) 2019 2019 Increase/(decrease) % Income Income from Sale of Goods 364,354 190,462
THB 1,367. 62 million, and other current liabilities THB 574.94 million. Due to its strong position in cash flow and liquidity, the Company and its subsidiaries can repay the debt obligations including
amount THB 85.7 MB, equivalent to 45.0% of total revenue and can be summarized as the following: The Company’s revenue from sales amounted to THB 269.1 MB and THB 172.5 MB in Q2/2020 and 2019 respectively